Comments
Sun Pharmaceutical on Monday said it has received approval from the US health regulator to market generic Diltiazem HCl extended-release capsules used for treating hypertension and angina in the American market.
The company’s subsidiary has been granted approval by the United States Food and Drug Administration (USFDA) for the abbreviated new drug application (ANDA) to market generic Diltiazem HCl extended-release capsules, Sun Pharma said in a statement.
These Diltiazem HCl extended release capsules are generic equivalent to Valeant International’s Cardizem CD capsules in the strengths of 20 mg, 180 mg, 240 mg, 300 mg and 360 mg.
Diltiazem HCl extended—release capsules are indicated for the treatment of hypertension and for the management of angina.
Shares of Sun Pharmaceutical Industries today closed at Rs 503.30 on BSE, down 1.08 per cent from its previous close.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.